Search

Your search keyword '"Doss, Mirko"' showing total 19 results
Start Over Author "Doss, Mirko" Publication Year Range Last 3 years
19 results on '"Doss, Mirko"'

12. Impact of Initial Operative Urgency on Short-Term Outcomes in Patients Treated with ECMO Due to Postcardiotomy Cardiogenic Shock

Author

Ivanov, Borko, primary, Krasivskyi, Ihor, additional, Gerfer, Stephen, additional, Sabashnikov, Anton, additional, Doss, Mirko, additional, Holzhey, David, additional, Eghbalzadeh, Kaveh, additional, Rustenbach, Christian, additional, Kuhn, Elmar, additional, Rahmanian, Parwis Baradaran, additional, Mader, Navid, additional, Djordjevic, Ilija, additional, and Wahlers, Thorsten, additional

Published
2022
Full Text
View/download PDF

14. Impact of Initial Operative Urgency on Short-Term Outcomes in Patients Treated with ECMO Due to Postcardiotomy Cardiogenic Shock

Author

Ivanov, Borko, Krasivskyi, Ihor, Gerfer, Stephen, Sabashnikov, Anton, Doss, Mirko, Holzhey, David, Eghbalzadeh, Kaveh, Rustenbach, Christian, Kuhn, Elmar, Rahmanian, Parwis Baradaran, Mader, Navid, Djordjevic, Ilija, Wahlers, Thorsten, Ivanov, Borko, Krasivskyi, Ihor, Gerfer, Stephen, Sabashnikov, Anton, Doss, Mirko, Holzhey, David, Eghbalzadeh, Kaveh, Rustenbach, Christian, Kuhn, Elmar, Rahmanian, Parwis Baradaran, Mader, Navid, Djordjevic, Ilija, and Wahlers, Thorsten

Abstract

The outcomes of patients with PCS and following ECMO therapy are associated with several preoperative risk factors. Our aim was to compare clinical presentation, ECMO-related data and in-hospital outcomes of patients treated with ECMO due to PCS after cardiac surgery, in regard to elective or emergent cardiac surgery procedures. Between April 2006 and October 2016, 164 consecutive patients that received VA-ECMO therapy due to PCS were identified and included in this retrospective cohort study. The patients were divided into groups based on the urgency of the initial procedures performed: elective group (ELG; n = 95) and an emergency group (EMG; n = 69). To compare the unequal patient groups, a propensity score-based matching (PSM) was applied (ELG, n = 56 vs. EMG, n = 56). The EMG primarily received ECMO intraoperatively (p <= 0.001). In contrast, the ELG were needed ECMO support more frequently postoperatively (p < 0.001). In-hospital mortality accounted for 71% (n = 40) in the ELG and 76% (n = 43) in the EMG (p = 0.518). Outcome data showed no major differences in the (abdominal ischemia (p = 0.371); septic shock (p = 0.393): rhythm disturbances (p = 0.575); emergency re-thoracotomy (p = 0.418)) between the groups. The urgency of the initial procedures performed is secondary in patients suffering PCS and following ECMO. In this regard, PCS itself seems to trigger outcomes in cardiac surgery ECMO patients substantially.

Published
2022

16. Acute right atrial thrombus formation after extracorporeal life support removal during LVAD-implantation.

Author

Woehrle, Anne, Sachs, Alexander, Doss, Mirko, and Popov, Aron Frederik

Abstract

A 58-year-old male underwent LVAD-Implantation after ECLS explantation. After removal of ECLS (A) transesophageal echocardiography revealed thrombus in the inferior vena cava (B) and right atrium (C). The thrombus was removed with a second pump run including RVAD-Implantation. (D) The diameter of thrombus formations was 6 × 1 cm and 5 × 1.5 cm. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

18. Transcatheter edge-to-edge valve repair versus minimally invasive beating-heart surgery of the tricuspid valve: an observational study.

Author

Wilde N, Silaschi M, Alirezaei H, Vogelhuber J, Sugiura A, Tanaka T, Sudo M, Kavsur R, Cattelaens F, El-Sayed Ahmad A, Doss M, Fehske W, Zimmer S, Nickenig G, Bakhtiary F, and Weber M

Subjects
Humans, Tricuspid Valve surgery, Treatment Outcome, Cardiac Catheterization, Tricuspid Valve Insufficiency surgery, Heart Valve Prosthesis Implantation
Published
2023
Full Text
View/download PDF

19. 1-Year Patency of Biorestorative Polymeric Coronary Artery Bypass Grafts in an Ovine Model.

Author

Ono M, Kageyama S, O'Leary N, El-Kurdi MS, Reinöhl J, Solien E, Bianco RW, Doss M, Meuris B, Virmani R, Cox M, Onuma Y, and Serruys PW

Abstract

Many attempts have been made to inhibit or counteract saphenous vein graft (SVG) failure modes; however, only external support for SVGs has gained momentum in clinical utility. This study revealed the feasibility of implantation, and showed good patency out to 12 months of the novel biorestorative graft, in a challenging ovine coronary artery bypass graft model. This finding could trigger the first-in-man trial of using the novel material instead of SVG. We believe that, eventually, this novel biorestorative bypass graft can be one of the options for coronary artery bypass graft patients who have difficulty harvesting SVG., Competing Interests: The work described in this paper was fully funded by Xeltis BV. Drs El-Kurdi, Reinöhl, and Cox are all employees of Xeltis. Dr Virmani has received personal fees from Xeltis, and Medtronic; as well as Institutional grants from Abbott Vascular, Boston Scientific, Medtronic, Xeltis and Becton Dickinson. Prof. Onuma has received institutional research grants related to his work as the Chairman of cardiovascular imaging core labs of several clinical trials and registries sponsored by industry, for which he receives no direct compensation. Prof. Serruys has received personal fees from Sino Medical Sciences Technology, Philips/Volcano and Xeltis. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., (© 2023 The Authors.)

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results